Skip to main content

Table 2 Maternal serum PlGF and sFLT-1 levels and their ratio

From: Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis

 

PE (n = 12)

No PE (n = 38)

P-valuea

Others (n = 16) (Uncomplicated)

GH (n = 16)

P-valueb

Normotensive IUGR (n = 6)

P-valuec

Delivery < 34 weeks (n = 7)

Delivery ≥ 34 weeks (n = 44)

P-valued

PlGF (pg/mL)

105.6 (70.7-248.7)

218.5 (131.2-322.5)

0.041

274.6 (157.9-413.6)

198.7 (91.5-305.3)

0.142

165.9 (72.1-220.7)

0.033

75.1 (64.6-131.7)

221.7 (117.4-336.4)

0.003

sFLT-1 (pg/mL)

1879.0 (1379.5-2168.3)

1144.0 (842.2-1882.8)

0.046

1458.0 (1018.8-1896.3)

1032.6 (826.8-1649.8)

0.258

1324.4 (673.1-2012.0)

0.768

2158.0 (1858.0-3463.0)

1298.0 (846.1-1876.0)

0.008

sFLT-1/PlGF ratio

18.8 (4.8-29.1)

6.2 (3.4-8.8)

0.022

5.9 (2.9-8.6)

5.9 (3.6-9.1)

0.366

8.6 (4.0-19.6)

0.161

29.4 (14.1-53.9)

6.0 (3.4-9.0)

0.001

  1. Data are given as median (interquartile range).
  2. a Mann–Whitney statistical test comparing PE vs No PE.
  3. b Mann–Whitney statistical test comparing GH vs Others.
  4. c Mann–Whitney statistical test comparing IUGR vs Others.
  5. d Mann–Whitney statistical test comparing delivery < 34 weeks vs delivery ≥ 34 weeks.
  6. PE = Preeclampsia, GH = Gestational hypertension, IUGR = Intrauterine growth restriction.